Oncolytics Biotech, Inc. (ONCY)
0.9348
-0.13
(-11.81%)
USD |
NASDAQ |
Jun 02, 16:00
0.94
+0.01
(+0.56%)
After-Hours: 20:00
Oncolytics Biotech EPS Diluted (Quarterly) : -0.0823 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Replimune Group, Inc. | -0.7694 |
| Arrowhead Pharmaceuticals, Inc. | -0.932 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | 2.878 |
| Anixa Biosciences, Inc. | -0.0772 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.243M |
| Total Expenses (Quarterly) | 9.243M |
| Enterprise Value | 121.53M |
| Earnings Yield | -26.93% |
| Normalized Earnings Yield | -26.57 |